Position in SGMOQ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,567,610
-$429,907 QoQ
Shares Held
6,270,441
+31.8% QoQ
Ownership
1.51%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in SGMOQ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in SGMOQ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,567,610 | 6,270,441 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,997,517 | 4,755,995 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,661,054 | 2,479,186 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $473,622 | 877,079 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $519,251 | 786,745 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,032,892 | 1,012,640 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $273,479 | 314,344 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $195,549 | 543,194 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $371,752 | 554,855 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,174,031 | 2,174,133 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $537,856 | 896,427 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,608,384 | 1,237,219 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,637,667 | 930,493 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,409,898 | 1,085,955 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,737,782 | 1,170,976 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,017,356 | 728,830 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,093,877 | 360,392 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,632,550 | 484,340 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,947,199 | 438,091 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,426,070 | 536,848 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $11,499,181 | 917,732 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $19,577,172 | 1,254,143 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $16,814,479 | 1,779,310 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $19,044,793 | 2,125,535 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $6,037,511 | 947,804 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||